Mineralys Therapeutics (MLYS) Other Non Operating Income (2022 - 2026)
Quarterly results put Other Non Operating Income at $5000.0 for Q1 2026, up 266.67% from a year ago — trailing twelve months through Mar 2026 was $8000.0 (up 700.0% YoY), and the annual figure for FY2024 was $5000.0, up 66.67%.
Mineralys Therapeutics has reported Other Non Operating Income over the past 5 years, most recently at $5000.0 for Q1 2026.
- Other Non Operating Income reached $5000.0 in Q1 2026 per MLYS's latest filing, up from $1000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $12000.0 in Q4 2024 and bottomed at -$10000.0 in Q3 2024.
- Median Other Non Operating Income over the past 5 years was $1000.0 (2023), compared with a mean of $1307.7.
- The largest annual shift saw Other Non Operating Income soared 1100.0% in 2024 before it tumbled 400.0% in 2025.
- Over 5 years, Other Non Operating Income stood at $4000.0 in 2022, then tumbled by 75.0% to $1000.0 in 2023, then skyrocketed by 1100.0% to $12000.0 in 2024, then tumbled by 91.67% to $1000.0 in 2025, then skyrocketed by 400.0% to $5000.0 in 2026.
- Business Quant data shows Other Non Operating Income for MLYS at $5000.0 in Q1 2026, $1000.0 in Q4 2025, and $4000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -2,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 12,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Sep 30, 2022 | 4,000.00 |